The automatic diagnosis of Alzheimer’s disease plays an important role in human health, especially in its early stage. Because it is a neurodegenerative condition, Alzheimer’s disease seems to have a long incubation period. Therefore, it is essential to analyze Alzheimer’s symptoms at different stages. In this paper, the classification is done with several methods of machine learning consisting of K -nearest neighbor (KNN), support vector machine (SVM), decision tree (DT), linear discrimination analysis (LDA), and random forest (RF). Moreover, novel convolutional neural network (CNN) architecture is presented to diagnose Alzheimer’s severity. The relationship between Alzheimer’s patients’ functional magnetic resonance imaging (fMRI) images and their scores on the MMSE is investigated to achieve the aim. The feature extraction is performed based on the robust multitask feature learning algorithm. The severity is also calculated based on the Mini-Mental State Examination score, including low, mild, moderate, and severe categories. Results show that the accuracy of the KNN, SVM, DT, LDA, RF, and presented CNN method is 77.5%, 85.8%, 91.7%, 79.5%, 85.1%, and 96.7%, respectively. Moreover, for the presented CNN architecture, the sensitivity of low, mild, moderate, and severe status of Alzheimer patients is 98.1%, 95.2%,89.0%, and 87.5%, respectively. Based on the findings, the presented CNN architecture classifier outperforms other methods and can diagnose the severity and stages of Alzheimer’s disease with maximum accuracy.
Alzheimer’s disease (AD) consists of the gradual process of decreasing volume and quality of neuron connection in the brain, which consists of gradual synaptic integrity and loss of cognitive functions. In recent years, there has been significant attention in AD classification and early detection with machine learning algorithms. There are different neuroimaging techniques for capturing data and using it for the classification task. Input data as images will help machine learning models to detect different biomarkers for AD classification. This marker has a more critical role for AD detection than other diseases because beta-amyloid can extract complex structures with some metal ions. Most researchers have focused on using 3D and 4D convolutional neural networks for AD classification due to reasonable amounts of data. Also, combination neuroimaging techniques like functional magnetic resonance imaging and positron emission tomography for AD detection have recently gathered much attention. However, gathering a combination of data can be expensive, complex, and tedious. For time consumption reasons, most patients prefer to throw one of the neuroimaging techniques. So, in this review article, we have surveyed different research studies with various neuroimaging techniques and ML methods to see the effect of using combined data as input. The result has shown that the use of the combination method would increase the accuracy of AD detection. Also, according to the sensitivity metrics from different machine learning methods, MRI and fMRI showed promising results.
Using strategies that obtain biomarkers where early symptoms coincide, the early detection of Alzheimer’s disease and its complications is essential. Electroencephalogram is a technology that allows thousands of neurons with equal spatial orientation of the duration of cerebral cortex electrical activity to be registered by postsynaptic potential. Therefore, in this paper, the time-dependent power spectrum descriptors are used to diagnose the electroencephalogram signal function from three groups: mild cognitive impairment, Alzheimer’s disease, and healthy control test samples. The final feature used in three modes of traditional classification methods is recorded: k -nearest neighbors, support vector machine, linear discriminant analysis approaches, and documented results. Finally, for Alzheimer’s disease patient classification, the convolutional neural network architecture is presented. The results are indicated using output assessment. For the convolutional neural network approach, the accurate meaning of accuracy is 82.3%. 85% of mild cognitive impairment cases are accurately detected in-depth, but 89.1% of the Alzheimer’s disease and 75% of the healthy population are correctly diagnosed. The presented convolutional neural network outperforms other approaches because performance and the k -nearest neighbors’ approach is the next target. The linear discriminant analysis and support vector machine were at the low area under the curve values.
This study will concentrate on recent research on EEG signals for Alzheimer’s diagnosis, identifying and comparing key steps of EEG-based Alzheimer’s disease (AD) detection, such as EEG signal acquisition, preprocessing function extraction, and classification methods. Furthermore, highlighting general approaches, variations, and agreement in the use of EEG identified shortcomings and guidelines for multiple experimental stages ranging from demographic characteristics to outcomes monitoring for future research. Two main targets have been defined based on the article’s purpose: (1) discriminative (or detection), i.e., look for differences in EEG-based features across groups, such as MCI, moderate Alzheimer’s disease, extreme Alzheimer’s disease, other forms of dementia, and stable normal elderly controls; and (2) progression determination, i.e., look for correlations between EEG-based features and clinical markers linked to MCI-to-AD conversion and Alzheimer’s disease intensity progression. Limitations mentioned in the reviewed papers were also gathered and explored in this study, with the goal of gaining a better understanding of the problems that need to be addressed in order to advance the use of EEG in Alzheimer’s disease science.
There is a wide variety of effects of Alzheimer’s disease (AD), a neurodegenerative disease that can lead to cognitive decline, deterioration of daily life, and behavioral and psychological changes. A polymorphism of the ApoE gene ε 4 is considered a genetic risk factor for Alzheimer’s disease. The purpose of this paper is to demonstrate that single-nucleotide polymorphic markers (SNPs) have a causal relationship with quantitative PET imaging traits. Additionally, the classification of AD is based on the frequency of brain tissue variations in PET images using a combination of k-nearest-neighbor (KNN), support vector machine (SVM), linear discrimination analysis (LDA), and convolutional neural network (CNN) techniques. According to the results, the suggested SNPs appear to be associated with quantitative traits more strongly than the SNPs in the ApoE genes. Regarding the classification result, the highest accuracy is obtained by the CNN with 91.1%. These results indicate that the KNN and CNN methods are beneficial in diagnosing AD. Nevertheless, the LDA and SVM are demonstrated with a lower level of accuracy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.